Adamis Pharma Price History

ADMPDelisted Stock  USD 1.74  0.24  12.12%   
If you're considering investing in Adamis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Adamis Pharma stands at 1.74, as last reported on the 29th of November, with the highest price reaching 1.99 and the lowest price hitting 1.67 during the day. We have found twenty-three technical indicators for Adamis Pharma, which you can use to evaluate the volatility of the firm. Please confirm Adamis Pharma's mean deviation of 4.75, and Risk Adjusted Performance of (0.19) to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Adamis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ADMP
Based on monthly moving average Adamis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adamis Pharma by adding Adamis Pharma to a well-diversified portfolio.

Adamis Pharma Stock Price History Chart

There are several ways to analyze Adamis Stock price data. The simplest method is using a basic Adamis candlestick price chart, which shows Adamis Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Adamis Stock Price History Data

The price series of Adamis Pharma for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 4.98 with a coefficient of variation of 49.52. The prices are distributed with arithmetic mean of 3.33. The median price for the last 90 days is 2.3. The company had 1:70 stock split on 22nd of May 2023.
OpenHighLowCloseVolume
11/29/2024
 1.98  1.99  1.67  1.74 
07/24/2023 1.98  1.99  1.67  1.74  127,285 
07/21/2023 2.01  2.05  1.80  1.90  120,900 
07/20/2023 1.99  2.04  1.92  2.01  76,491 
07/19/2023 2.03  2.09  1.97  2.00  58,319 
07/18/2023 2.02  2.12  2.01  2.05  37,920 
07/17/2023 2.13  2.21  2.01  2.04  58,543 
07/14/2023 2.25  2.28  2.08  2.08  103,348 
07/13/2023 2.33  2.44  2.30  2.31  70,290 
07/12/2023 2.22  2.59  2.19  2.30  191,987 
07/11/2023 2.17  2.28  2.16  2.20  30,954 
07/10/2023 2.14  2.25  2.13  2.18  42,021 
07/07/2023 2.11  2.16  2.06  2.15  30,941 
07/06/2023 2.11  2.21  2.03  2.09  66,195 
07/05/2023 2.44  2.44  2.11  2.15  98,033 
07/03/2023 2.42  2.53  2.25  2.36  53,451 
06/30/2023 2.38  2.45  2.26  2.41  65,653 
06/29/2023 2.09  2.64  2.09  2.39  327,697 
06/28/2023 2.21  2.21  2.08  2.09  52,089 
06/27/2023 2.24  2.26  2.04  2.19  157,549 
06/26/2023 2.04  2.40  1.92  2.27  3,123,804 
06/23/2023 2.05  2.05  1.96  2.04  32,345 
06/22/2023 2.00  2.09  1.94  2.02  39,628 
06/21/2023 2.25  2.28  1.90  1.90  167,449 
06/20/2023 2.16  2.35  2.11  2.33  57,895 
06/16/2023 2.10  2.16  2.07  2.15  34,292 
06/15/2023 1.98  2.13  1.98  2.12  33,208 
06/14/2023 2.21  2.21  2.04  2.08  62,850 
06/13/2023 1.99  2.15  1.99  2.12  54,089 
06/12/2023 2.01  2.10  1.92  1.95  61,896 
06/09/2023 2.05  2.10  2.02  2.05  35,397 
06/08/2023 2.13  2.17  2.04  2.04  50,570 
06/07/2023 2.21  2.24  2.08  2.16  51,754 
06/06/2023 2.07  2.37  2.07  2.20  149,861 
06/05/2023 2.15  2.17  2.01  2.17  58,263 
06/02/2023 2.11  2.16  2.02  2.07  45,611 
06/01/2023 2.09  2.13  2.05  2.09  46,432 
05/31/2023 2.13  2.13  2.00  2.09  60,566 
05/30/2023 2.07  2.15  2.00  2.12  89,388 
05/26/2023 2.60  2.60  1.91  2.07  911,967 
05/25/2023 2.77  2.81  2.50  2.50  73,367 
05/24/2023 2.83  2.94  2.67  2.77  94,902 
05/23/2023 3.19  3.22  2.81  2.82  136,987 
05/22/2023 3.24  3.87  3.09  3.19  291,696 
05/19/2023 4.90  4.96  3.33  3.50  179,845 
05/18/2023 0.07  4.76  4.76  4.76  20,680 
05/17/2023 5.15  5.15  4.29  4.62  27,904 
05/16/2023 5.95  5.95  4.41  4.87  32,848 
05/15/2023 5.72  5.74  4.75  4.90  33,304 
05/12/2023 0.08  5.53  5.53  5.53  19,286 
05/11/2023 0.09  5.60  5.60  5.60  46,361 
05/10/2023 0.08  5.60  5.60  5.60  35,499 
05/09/2023 0.07  4.90  4.90  4.90  20,502 
05/08/2023 0.07  4.98  4.98  4.98  18,271 
05/05/2023 0.08  4.90  4.90  4.90  14,701 
05/04/2023 0.08  5.46  5.46  5.46  15,521 
05/03/2023 0.08  5.32  5.32  5.32  10,081 
05/02/2023 0.08  5.68  5.68  5.68  19,506 
05/01/2023 0.08  5.63  5.63  5.63  18,225 
04/28/2023 0.09  5.81  5.81  5.81  6,674 
04/27/2023 0.08  5.65  5.65  5.65  12,645 

About Adamis Pharma Stock history

Adamis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adamis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adamis Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adamis Pharma stock prices may prove useful in developing a viable investing in Adamis Pharma
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. Adamis Pharmaceuticl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 15 people.

Adamis Pharma Stock Technical Analysis

Adamis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Adamis Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Adamis Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Adamis Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Adamis Pharma's price direction in advance. Along with the technical and fundamental analysis of Adamis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adamis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Adamis Stock

If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated